Predictive Value of Prostate Specific Antigen in a European HIV-positive Cohort: Does One Size Fit All?
暂无分享,去创建一个
A. Mocroft | O. Kirk | J. Lundgren | G. Kronborg | M. Silverberg | L. Shepherd | A. Grulich | M. Galli | M. Bower | Á. Borges | L. Ravn | R. Harvey
[1] S. K. Van Den Eeden,et al. Prostate Cancer Incidence and Prostate-Specific Antigen Testing Among HIV-Positive and HIV-Negative Men , 2014, Journal of acquired immune deficiency syndromes.
[2] Mohammad Hassan Murad,et al. Early detection of prostate cancer: AUA Guideline. , 2013, The Journal of urology.
[3] Andrew N. Phillips,et al. Projected life expectancy of people with HIV according to timing of diagnosis , 2012, AIDS.
[4] J. Gohagan,et al. Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up. , 2012, Journal of the National Cancer Institute.
[5] A. Justice,et al. Cancer Screening in Patients Infected with HIV , 2011, Current HIV/AIDS reports.
[6] A. Mocroft,et al. Serious Fatal and Nonfatal Non-AIDS-Defining Illnesses in Europe , 2010, Journal of acquired immune deficiency syndromes.
[7] A. Phillips,et al. HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity , 2009, BMJ : British Medical Journal.
[8] Andrew J Vickers,et al. Systematic review of pretreatment prostate-specific antigen velocity and doubling time as predictors for prostate cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] P. Sullivan,et al. Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. , 2008, Annals of internal medicine.
[10] A. Roddam,et al. Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies. , 2008, Journal of the National Cancer Institute.
[11] M. Falster,et al. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis , 2007, The Lancet.
[12] C. Amling,et al. Prostate carcinoma among men with human immunodeficiency virus infection , 2004, Cancer.
[13] A. Klibanski,et al. Prevalence of hypogonadism among men with weight loss related to human immunodeficiency virus infection who were receiving highly active antiretroviral therapy. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[14] J. Moul,et al. Prostate-specific antigen levels in young white and black men 20 to 45 years old. , 2000, Urology.
[15] D. Ornstein,et al. Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements. , 1997, JAMA.
[16] J. Richie,et al. COMPARISON OF DIGITAL RECTAL EXAMINATION AND SERUM PROSTATE SPECIFIC ANTIGEN IN THE EARLY DETECTION OF PROSTATE CANCER: RESULTS OF A MULTICENTER CLINICAL TRIAL OF 6,630 MEN , 1994, The Journal of urology.
[17] T. Tammela,et al. Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up , 2014, The Lancet.
[18] Thomas Wiegel,et al. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. , 2011, European urology.